Li M, Li X, Qiu B, Chen Y, Jiang P, Sun H
Clin Exp Med. 2025; 25(1):52.
PMID: 39928184
PMC: 11811234.
DOI: 10.1007/s10238-025-01575-5.
Yu J, Chen C, Lu M, Fang X, Li J, Zhu M
Int J Surg. 2025; 110(12):7656-7670.
PMID: 39806736
PMC: 11634086.
DOI: 10.1097/JS9.0000000000001604.
Li Y, Guo L, Xie P, Liu Y, Li Y, Liu A
BMC Med Imaging. 2024; 24(1):310.
PMID: 39548404
PMC: 11568675.
DOI: 10.1186/s12880-024-01492-1.
Chen H, Chen C, Liao W, Lin Y, Chen H, Hsia T
BMC Pulm Med. 2024; 24(1):517.
PMID: 39415161
PMC: 11481380.
DOI: 10.1186/s12890-024-03336-8.
Xun Z, Zhou H, Shen M, Liu Y, Sun C, Du Y
Adv Sci (Weinh). 2024; 11(33):e2309885.
PMID: 38956900
PMC: 11434037.
DOI: 10.1002/advs.202309885.
SIVA-1 interaction with PCBP1 serves as a predictive biomarker for cisplatin sensitivity in gastric cancer and its inhibitory effect on tumor growth .
Kong F, Shi Z, Huang Y, Chen H, Deng Q, Wu K
J Cancer. 2024; 15(13):4301-4312.
PMID: 38947376
PMC: 11212092.
DOI: 10.7150/jca.92963.
Multi-index comprehensive evaluation of the efficacy and response mechanism of immunotherapy in non-small cell lung cancer.
Fan J, Zhang T
Clin Transl Oncol. 2024; 26(12):3124-3130.
PMID: 38822977
DOI: 10.1007/s12094-024-03519-z.
Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts.
Chen X, Cheng G, Zhu L, Liu T, Yang X, Liu R
Cell Rep Med. 2024; 5(6):101576.
PMID: 38776909
PMC: 11228400.
DOI: 10.1016/j.xcrm.2024.101576.
Exosomal circ_0032704 confers sorafenib resistance to hepatocellular carcinoma and contributes to cancer malignant progression by modulating the miR-514a-3p/PD-L1 pathway.
Dou C, Zhu H, Xie X, Huang C, Tan H, Cao C
Ann Gastroenterol Surg. 2024; 8(3):507-520.
PMID: 38707229
PMC: 11066485.
DOI: 10.1002/ags3.12772.
The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q, Tan L, Tang X, Wang W, Su Y, Wu Z
Front Endocrinol (Lausanne). 2024; 15:1327766.
PMID: 38686207
PMC: 11056783.
DOI: 10.3389/fendo.2024.1327766.
Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis.
Ling Q, Huang S, Yu T, Liu H, Zhao L, Chen X
World J Surg Oncol. 2023; 21(1):377.
PMID: 38037067
PMC: 10690980.
DOI: 10.1186/s12957-023-03251-y.
Prognostic Value of Mandard's Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer.
Scaglione G, Arciuolo D, Travaglino A, Santoro A, Angelico G, Spadola S
Diagnostics (Basel). 2023; 13(20).
PMID: 37892049
PMC: 10605878.
DOI: 10.3390/diagnostics13203228.
Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study.
Lang M, Gan L, Ren S, Han R, Ma X, Li G
Am J Cancer Res. 2023; 13(6):2540-2553.
PMID: 37424821
PMC: 10326569.
Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer.
Uno M, Matsuo R, Maezawa N, Kato T
Obstet Gynecol Sci. 2023; 66(4):290-299.
PMID: 37380167
PMC: 10375218.
DOI: 10.5468/ogs.23024.
The efficacy and safety of first‑line anti‑PD‑1/PD‑L1 immunotherapy for gastric esophageal cancer: A systematic review and meta‑analysis of phase III randomized controlled trials.
Duan X, Du H, Qi R, Yuan M, Shi J
Exp Ther Med. 2023; 25(5):216.
PMID: 37123204
PMC: 10133786.
DOI: 10.3892/etm.2023.11915.
A novel nomogram model of breast cancer-based imaging for predicting the status of axillary lymph nodes after neoadjuvant therapy.
Zhang P, Song X, Sun L, Li C, Liu X, Bao J
Sci Rep. 2023; 13(1):5952.
PMID: 37045864
PMC: 10097686.
DOI: 10.1038/s41598-023-29967-1.
Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer.
Ding H, Yang Q, Mao Y, Qin D, Yao Z, Wang R
J Inflamm Res. 2023; 16:1297-1310.
PMID: 36998322
PMC: 10045337.
DOI: 10.2147/JIR.S404900.
DCNAS-Net: deformation convolution and neural architecture search detection network for bone marrow oedema.
Song C, Zhu S, Liu Y, Zhang W, Wang Z, Li W
BMC Med Imaging. 2023; 23(1):45.
PMID: 36978011
PMC: 10045610.
DOI: 10.1186/s12880-023-01003-8.
Efficacy and safety of Camrelizumab combined with Abraxane + lobaplatin regimen for advanced gastric cancer.
Ma J, Zhang W, Du J, Li J, Lin G, Tian Y
Am J Transl Res. 2023; 15(2):1485-1493.
PMID: 36915742
PMC: 10006821.
Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
Liu J, Li J, Yan S, Zhang G, Yi P
Front Oncol. 2023; 13:1074793.
PMID: 36910612
PMC: 9995877.
DOI: 10.3389/fonc.2023.1074793.